Related Experiment Video
Updated: Aug 11, 2026
07:23
Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Low efficacy opioids: implications for sex differences in opioid antinociception
1Alcohol and Drug Abuse Research Center, McLean Hospital, Harvard Medical School, Belmont, MA 02478, USA. abarrett@mclean.harvard
Experimental and Clinical Psychopharmacology
|March 1, 2006
Summary
Sex significantly impacts how organisms respond to opioid pain relief. Lower efficacy opioids reveal larger sex differences in potency, suggesting fundamental differences in opioid system function between males and females.
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- Sex is a critical factor influencing opioid analgesic responses.
- Understanding sex differences in opioid antinociception is crucial but not fully elucidated.
- Opioid relative efficacy is a key factor potentially explaining these sex differences.
Purpose of the Study:
- To review findings on how opioid efficacy influences sex differences in opioid system function.
- To investigate the role of opioid efficacy in modulating sex-based variations in antinociception.
- To explore the broader implications of these findings in behavioral pharmacology.
Main Methods:
- Systematic manipulation of opioid efficacy as an independent variable.
- Analysis of data from rodent and nonhuman primate studies.
- Comparison of sex differences in potency and efficacy across various opioid types.
Main Results:
- Mu and kappa opioids are generally more potent and effective in males than females.
- Sex differences in potency are smaller for high efficacy opioids (e.g., morphine) (<3.0-fold).
- Sex differences in potency are significantly larger for low efficacy opioids (>90-fold), with potential agonist/antagonist activity differences.
Conclusions:
- Opioid efficacy is a critical variable in understanding sex differences in antinociception.
- Fundamental sex differences in opioid system function are suggested by varying drug efficacy effects.
- Other factors like drug history, genotype, and stimulus parameters interact with efficacy to shape observed sex differences.
Related Concept Videos
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
01:22Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
01:17Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
01:22Dose-Response Relationship: Potency and Efficacy
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...